Skip Navigation



Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology | Family Medicine
Disease Category: High Blood Pressure (Hypertension)
Location: United States, FL

Clinical Trial Details


Research Study Summary

Do you have trouble controlling your Hypertension?


This is a Phase 3 double-blind, randomized study to evaluate the efficacy and safety comparing the TAK-491 plus fixed dose combination to another HTN medication in subjects with moderate to severe essential hypertension, The study will last 12 weeks with 11 office visits, and you may be compensated for your time and travel upon completion of study.

Patient Inclusion Criteria:

  • Male/female age 18 and up
  • Treated with antihypertensive therapy
  • Female subjects of childbearing potential must use proper form of birth control

Patient Exclusion Criteria:

  • Subject has recent history (within 6 months) of MI, heart failure, unstable angina, CABG, coronary intervention, hypertensive encephalopathy, cerebrovascular accident, TIA
  • Subject has clinically significant cardiac conduction defects, sick sinus syndrome, atrial fibrillation, atrial flutter, aortic vavular disease
  • Renal dysfunction or disease, suspected unilateral or bilateral renal artery stenosis
  • Cancer within the last 5 years (BCC or SCC ok )
  • Subject has type 1 or poorly controlled type 2 DM (HbA1c >8.0%)
  • Any uncontrolled medical condition
  • Female patients pregnant or lactating
  • Participated in an investigational study within the last 30 days
  • Subject has been randomized in previous TAK-491 study
  • History of drug or alcohol abuse within the past 2 years

To Learn more



Both Male and Female


18 and up

Overall Status



12 Weeks

Facility Type



Renstar Medical Research
104 SE 1st Ave., Suite B
Ocala, FL 34471
Phone: 352-629-5800

View Map

Research Center Information: Renstar Medical Research

CW ID: 154269

Date Last Changed: July 24, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.